Pathological regression in patients with microsatellite instability   (MSI) receiving perioperative atezolizumab in combination with FLOT vs.   FLOT alone for resectable esophagogastric adenocarcinoma: Results from   the DANTE trial of the German Gastric Group at the AIO and SAKK

Titel:: Pathological regression in patients with microsatellite instability (MSI) receiving perioperative atezolizumab in combination with FLOT vs. FLOT alone for resectable esophagogastric adenocarcinoma: Results from the DANTE trial of the German Gastric Group at the AIO and SAKK
Dokumenttyp:: Meeting Abstract
Autor(en):: Al-Batran, S-E.; Lorenzen, S.; Homann, N.; Thuss-Patience, P. C.; Schenk, M.; Lindig, U.; Kretzschmar, A.; Heuer, V.; Goekkurt, E.; Haag, G. M.; Knorrenschild, J. Riera; Bolling, C.; Hofheinz, R. D.; Siebenhuener, A. R.; Irahara, N.; Kopp, C.; Waberer, L.; Pauligk, C.; Gotze, T. O.; Gaiser, T.
Zeitschriftentitel:: Ann Oncol
Jahr:: 2021
Band / Volume:: 32 Suppl 5
Seitenangaben Beitrag:: S1069-S1069
Volltext / DOI:: doi:10.1016/j.annonc.2021.08.1538
Print-ISSN:: 0923-7534
TUM Einrichtung:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Vorkommen: